Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

By C. Palles, J. Cazier, K. Howarth, E. Domingo, A. Jones, P. Broderick, Z. Kemp, S. Spain, Estrella Guarino Almeida, I. Salguero and 27 more. Nature Genetics, 2012

943 citations recorded by the source corpus.

Many individuals with multiple or large colorectal adenomas or early-onset colorectal cancer (CRC) have no detectable germline mutations in the known cancer predisposition genes. Using whole-genome sequencing, supplemented by linkage and association analysis, we identified specific heterozygous POLE or POLD1 germline variants in several multiple-adenoma and/or CRC cases but in no controls. The variants associated with susceptibility, POLE p.Leu424Val and POLD1 p.Ser478Asn, have high penetrance, and POLD1 mutation was also associated with endometrial cancer predisposition. The mutations map to equivalent sites in the proofreading (exonuclease) domain of DNA polymerases ɛ and δ and are predicted to cause a defect in the correction of mispaired bases inserted during DNA replication. In agreement with this prediction, the tumors from mutation carriers were microsatellite stable but tended to acquire base substitution mutations, as confirmed by yeast functional assays. Further analysis of published data showed that the recently described group of hypermutant, microsatellite-stable CRCs is likely to be caused by somatic POLE mutations affecting the exonuclease domain.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/45b356c7cd2dd821091e71cd7b0bd75e833458a6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

  1. Daniel S Lieber

In Oncology

  1. Vincent A. Miller
  2. J. Chmielecki

Citations in the corpus